HERV2365 upregulates FGF1 expression by sponging miR-326 to promote the progression of intrahepatic cholangiocarcinoma
Yang Zhong, Xin Jiang, Fei Wang, Jianbin Xiao, Qiang Feng, Guixian Ye, Zefeng Gao, Jianmin Wang, Jingfeng Liu
Journal:iScience
IF:4.5
DOI:10.1016/j.isci.2026.115852
PMID:42164859
Published:2026-04-22
research field:肿瘤学分子生物学癌症研究非编码RNA肝脏病学
Abstract
Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with a dismal prognosis, underscoring the need to identify previously unrecognized molecular regulators involved in ICC progression. Although human endogenous retroviruses (HERVs) are aberrantly activated in multiple malignancies, their role in ICC remains poorly defined. Here, through integrative profiling of bulk and single-cell transcriptomes, we identified HERV2365 as a key upregulated oncogenic factor, which was enriched in ICC malignant cells and associated with poor prognosis. Functional assays demonstrated that HERV2365 enhanced ICC proliferation and tumorigenesis both in vitro and in vivo . Mechanistically, HERV2365 sponged miR-326, thereby derepressing fibroblast growth factor 1 (FGF1) and promoting tumor growth. Collectively, our findings identified HERV2365 as an unfavorable prognostic marker by promoting ICC progression through regulating the miR-326/FGF1 axis. Hepatology; Molecular biology; Cancer
本文使用的Yeasen产品


